Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on November 14, 2007, regarding events occurring on November 13, 2007. The filing announces the release of financial results for the fiscal quarter ended September 30, 2007.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the body of this Form 8-K. The document serves solely to notify the market of the issuance of the quarterly results press release.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. It explicitly states that the information, including the referenced press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing the full text of the press release dated November 13, 2007 (Exhibit 99.1).
- Confirm the company name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Check subsequent filings for any updates or corrections to the September 30, 2007, results.